Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Josep Comin‐Colet"'
Autor:
Raúl Ramos-Polo, Maria del Mar Ras-Jiménez, Josep Francesch Manzano, Silvia Jovells-Vaqué, Herminio Morillas Climent, Alexandra Pons-Riverola, Sergi Yun Viladomat, Pedro Moliner Borja, Carles Diez-Lopez, José González-Costello, Elena Garcia-Romero, Lorena Herrador, Fernando de Frutos Seminario, Cristina Enjuanes Grau, Marta Tajes Orduña, Josep Comin-Colet
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 16, p 4742 (2024)
Background. Iron deficiency (ID) is a significant, high-prevalence comorbidity in chronic heart failure (HF) that represents an independent predictor of a worse prognosis. However, a clear-cut diagnosis of ID in HF patients is not assured. The solubl
Externí odkaz:
https://doaj.org/article/47a731d376674e81abf37a4b66b166fb
Autor:
Lidia Alcoberro, Pedro Moliner, Joan Vime, Santiago Jiménez-Marrero, Alberto Garay, Sergi Yun, Alexandra Pons-Riverola, Raúl Ramos-Polo, Mar Ras-Jiménez, Marta Tajes, Encarna Hidalgo, Esther Calero, Marta Ruiz, Nuria José-Bazán, Carles Ferre, Cristina Delso, Laia Alcober, Cristina Enjuanes, Josep Comin-Colet
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0309956 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0279815.].
Externí odkaz:
https://doaj.org/article/32a2e0b4b1994264b5ae3a010715a18e
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 44-56 (2023)
Abstract Iron deficiency (ID) is a common co‐morbidity in patients with heart failure (HF). The present meta‐analysis evaluates the effect of intravenous (IV) iron‐carbohydrate complex supplementation in patients with HF with reduced ejection f
Externí odkaz:
https://doaj.org/article/fa567d28b5954d78beefcbbc4e46e7ad
Autor:
M Isabel Barrionuevo-Sánchez, Albert Ariza-Solé, Náyade del Prado, María García, José Carlos Sánchez-Salado, Victòria Lorente, Oriol Alegre, Isaac Llaó, José Luis Bernal, Cristina Fernández-Pérez, Francisco Galván-Román, Francisco de la Cuerda, Júlia Pascual, Angel Cequier, Josep Comin-Colet, Francisco Javier Elola
Publikováno v:
Hellenic Journal of Cardiology, Vol 69, Iss , Pp 16-23 (2023)
Background: A significant proportion of cases of cardiogenic shock (CS) are due aetiologies other than acute coronary syndromes (non ACS-CS). We assessed differences regarding clinical profile, management, and prognosis according to the cause of CS a
Externí odkaz:
https://doaj.org/article/ca6d8628a91d408abe6e090f293c9a2f
Autor:
Lidia Alcoberro, Pedro Moliner, Joan Vime, Santiago Jiménez-Marrero, Alberto Garay, Sergi Yun, Alexandra Pons-Riverola, Raúl Ramos-Polo, Mar Ras-Jiménez, Marta Tajes, Encarna Hidalgo, Esther Calero, Marta Ruiz, Nuria José-Bazán, Carles Ferre, Cristina Delso, Laia Alcober, Cristina Enjuanes, Josep Comin-Colet
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0279815 (2023)
Background and aimsHeart failure (HF) programs successfully reduce 30-day readmissions. However, conflicting data exist about its sustained effects afterwards and its impact on mortality. We evaluated whether the impact of a new nurse-led coordinated
Externí odkaz:
https://doaj.org/article/441fbb993cc7426b907509155c3a5aa5
Autor:
Maria del Mar Ras-Jiménez, Raúl Ramos-Polo, Josep Francesch Manzano, Miriam Corbella Santano, Herminio Morillas Climent, Núria Jose-Bazán, Santiago Jiménez-Marrero, Paloma Garcimartin Cerezo, Sergi Yun Viladomat, Pedro Moliner Borja, Blanca Torres Cardús, José Maria Verdú-Rotellar, Carles Diez-López, José González-Costello, Elena García-Romero, Fernando de Frutos Seminario, Laura Triguero-Llonch, Cristina Enjuanes Grau, Marta Tajes Orduña, Josep Comin-Colet
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 8, p 1282 (2023)
The soluble transferrin receptor (sTfR) is a marker of tissue iron status, which could indicate an increased iron demand at the tissue level. The impact of sTfR levels on functional capacity and quality of life (QoL) in non-anemic heart failure (HF)
Externí odkaz:
https://doaj.org/article/85cb13f2c4e64507997c2a71018e8491
Autor:
Emili Vela, Montse Cleries, Usama Bilal, Maciej Banach, John W McEvoy, Martin Bødtker Mortensen, Michael Joseph Blaha, Khurram Nasir, Josep Comin-Colet, Josepa Mauri, Miguel Cainzos-Achirica
Publikováno v:
Archives of Medical Science, Vol 19, Iss 1, Pp 35-45 (2021)
Introduction The ESC recently classified European countries into 4 cardiovascular risk regions. However, whether Europeans from higher-risk countries living in lower-risk regions may benefit from intensive cardiovascular prevention efforts is unknown
Externí odkaz:
https://doaj.org/article/99707d9e3f834f8c9a3b34a3545f7b16
Autor:
Ana Lucrecia Marcano, Montserrat Gracida, Gerard Roura, Josep Gomez-Lara, Rafael Romaguera, Luis Teruel, Lara Fuentes, Guillem Muntané-Carol, Oona Meroño, Silvia Gabriela Sosa, Joan Antoni Gómez-Hospital, Josep Comin-Colet, José Luis Ferreiro
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionPatients with diabetes mellitus (DM) have augmented platelet reactivity and diminished responsiveness to clopidogrel. Ticagrelor, a more potent P2Y12 inhibitor, is clinically superior to clopidogrel in acute coronary syndromes, although i
Externí odkaz:
https://doaj.org/article/1e83d0d921b24d6ba7e7792f64a0da71
Autor:
Pricila H. Mullachery, Emili Vela, Montse Cleries, Josep Comin‐Colet, Khurram Nasir, Ana V. Diez Roux, Miguel Cainzos‐Achirica, Josepa Mauri, Usama Bilal
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 17 (2022)
Background Understanding the magnitude of cardiovascular disease (CVD) inequalities is the first step toward addressing them. The linkage of socioeconomic and clinical data in universal health care settings provides critical information to characteri
Externí odkaz:
https://doaj.org/article/b157fd9adafb47638c6b7b3eef0c99be
Autor:
Helena Cristóbal, Cristina Enjuanes, Montserrat Batlle, Marta Tajes, Begoña Campos, Josep Francesch, Pedro Moliner, Marta Farrero, Rut Andrea, José Tomás Ortiz-Pérez, Albert Morales, Manel Sabaté, Josep Comin-Colet, Pablo García de Frutos
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 3, p 446 (2023)
Heart failure (HF) is classified according to the degree of reduction in left ventricular ejection fraction (EF) in HF with reduced, mildly reduced, and preserved EF. Biomarkers could behave differently depending on EF type. Here, we analyze the solu
Externí odkaz:
https://doaj.org/article/f8df55a151cb4eea9bab2be2131c7795